175 related articles for article (PubMed ID: 31824171)
1. Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway.
Xu T; Zhang R; Dong M; Zhang Z; Li H; Zhan C; Li X
Onco Targets Ther; 2019; 12():10639-10650. PubMed ID: 31824171
[TBL] [Abstract][Full Text] [Related]
2. Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway.
Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
J Exp Clin Cancer Res; 2018 Mar; 37(1):41. PubMed ID: 29499765
[TBL] [Abstract][Full Text] [Related]
3. AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-κB signaling pathway.
Qu J; Li J; Zhang Y; He R; Liu X; Gong K; Duan L; Luo W; Hu Z; Wang G; Xia C; Luo D
Cell Biosci; 2021 Aug; 11(1):163. PubMed ID: 34419144
[TBL] [Abstract][Full Text] [Related]
4. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
[TBL] [Abstract][Full Text] [Related]
5. Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling.
Mei Y; Du Z; Hu C; Greenwald NF; Abedalthagafi M; Agar NYR; Dunn GP; Bi WL; Santagata S; Dunn IF
Cell Commun Signal; 2017 Sep; 15(1):34. PubMed ID: 28923059
[TBL] [Abstract][Full Text] [Related]
6. LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/Akt/mTOR signaling pathway.
Bi QJ; Men XJ; Han R; Li GL
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3067-3073. PubMed ID: 29863252
[TBL] [Abstract][Full Text] [Related]
7. Osteoglycin (OGN) promotes tumorigenesis of pancreatic cancer cell via targeting ID4.
Qin W; Zhang J; Rong R; Zhang L; Gao H; Liu C; Ren Q; Zheng G; Wang J; Meng L; Qiao S; Qian R; Zhou C; Wang H; Zhang Y
Tissue Cell; 2022 Oct; 78():101867. PubMed ID: 35908351
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer.
Tian X; Wu L; Jiang M; Zhang Z; Wu R; Miao J; Liu C; Gao S
Front Oncol; 2021; 11():641399. PubMed ID: 33968740
[TBL] [Abstract][Full Text] [Related]
9. Osteoglycin silencing exerts inhibitory effects on myocardial fibrosis and epithelial/endothelial-mesenchymal transformation in a mouse model of myocarditis.
Fang Y; Chang Z; Xu Z; Hu J; Zhou H; Yu S; Wan X
Biofactors; 2020 Nov; 46(6):1018-1030. PubMed ID: 33141515
[TBL] [Abstract][Full Text] [Related]
10. Vertebrate SLRP family evolution and the subfunctionalization of osteoglycin gene duplicates in teleost fish.
Costa RA; Martins RST; Capilla E; Anjos L; Power DM
BMC Evol Biol; 2018 Dec; 18(1):191. PubMed ID: 30545285
[TBL] [Abstract][Full Text] [Related]
11. Osteoglycin: An ECM Factor Regulating Fibrosis and Tumorigenesis.
Nulali J; Zhan M; Zhang K; Tu P; Liu Y; Song H
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421687
[TBL] [Abstract][Full Text] [Related]
12. ECRG4 Represses Cell Proliferation and Invasiveness via NFIC/OGN/NF-κB Signaling Pathway in Bladder Cancer.
Liang X; Gao J; Wang Q; Hou S; Wu C
Front Genet; 2020; 11():846. PubMed ID: 32922434
[TBL] [Abstract][Full Text] [Related]
13. Chrysophanol inhibits the osteoglycin/mTOR and activats NF2 signaling pathways to reduce viability and proliferation of malignant meningioma cells.
Wang J; Lv P
Bioengineered; 2021 Dec; 12(1):755-762. PubMed ID: 33622177
[TBL] [Abstract][Full Text] [Related]
14. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma.
Zhang J; Liu S; Zhang D; Ma Z; Sun L
J Cell Biochem; 2019 Aug; 120(8):13717-13725. PubMed ID: 30938888
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
[TBL] [Abstract][Full Text] [Related]
16. C19orf10 promotes malignant behaviors of human bladder carcinoma cells via regulating the PI3K/AKT and Wnt/β-catenin pathways.
Li S; Mao L; Zhao F; Yan J; Song G; Luo Q; Li Z
J Cancer; 2021; 12(14):4341-4354. PubMed ID: 34093834
[No Abstract] [Full Text] [Related]
17. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.
Zheng J; Liu C; Shi J; Wen K; Wang X
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077
[TBL] [Abstract][Full Text] [Related]
18. miR-320/ELF3 axis inhibits the progression of breast cancer via the PI3K/AKT pathway.
Zhang Z; Zhang J; Li J; Geng H; Zhou B; Zhang B; Chen H
Oncol Lett; 2020 Apr; 19(4):3239-3248. PubMed ID: 32256819
[TBL] [Abstract][Full Text] [Related]
19. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
[TBL] [Abstract][Full Text] [Related]
20. Effecacy of Biejia (Carapax Trionycis) and Ezhu (Rhizoma Curcumae Phaeocaulis) couplet medicine on epithelial-mesenchymal transition, invasion and migration of MDA-MB-231 triple negative breast cancer cells via PI3K/Akt/mTOR signaling pathway.
Zhu MJ; Xie S; Xie Q; Zhu JL; Huang YZ
J Tradit Chin Med; 2021 Dec; 41(6):853-861. PubMed ID: 34939381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
